ETFS S&P Biotech ETF
ISIN AU0000028110
CURE
ETFS S&P Biotech ETF (CURE) aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index by holding all of the shares that make up the index closely in proportion to their index weights.
This ETF provides exposure to the US biotechnology sub-industry within the health care sector. The fund adopts an equally weighted strategy which gives higher exposure to small and mid-cap stocks held within the fund compared to market capitalisation weighted approach.
To be eligible for inclusion companies must be part of the Biotechnology sub-industry and meet minimum market capitalisation and liquidity requirements.
Insights
Product Information
Trading Information
Management & Administration
Benchmark Information
Allocation
Performance
Performance Table
| Total Return (%) the Fund | Total Return (%) benchmark | Tracking difference | Tracking error | |
|---|---|---|---|---|
| 1 Month | 0.54% | 0.66% | -0.12% | 0.55% |
| 3 Months | 19.50% | 19.86% | -0.36% | 0.56% |
| 6 Months | 13.45% | 13.85% | -0.40% | 0.57% |
| 1 Year | 21.62% | 22.49% | -0.87% | 0.65% |
| 3 Year p.a. | --- | --- | --- | --- |
| 5 Year p.a. | --- | --- | --- | --- |
| 10 Year p.a. | --- | --- | --- | --- |
| Since inception p.a. | 16.86% | 17.52% | -0.66% | 0.66% |
Historical Data
Distributions
Investment Research
Announcements
Resources